Comparison of gefitinib-induced skin adverse reactions (SAR) in C57BL/6 and FVB/N mice

Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) such as gefitinib, erlotinib, and afatinib, are widely used in clinical practice and remarkably effective in treatment of advanced non-small cell lung cancer. However, there are some adverse effects while taking EGFR-TKIs, among...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Toxicol Res (Camb)
Autors principals: Zhang, Yali, Wang, Yalei, Chen, Ziwei, Cheng, Shuo, Ding, Chengcheng, Zhang, Jiani, Peng, Tiantian, Chen, Weihang, Zhang, Dingyang, Tan, Yan, Wang, Xu, Dong, Ruijuan, Jiang, Miao, Hua, Qian
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2021
Matèries:
Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8045597/
https://ncbi.nlm.nih.gov/pubmed/33884183
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/toxres/tfab008
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars